Early Spironolactone Treatment Attenuates Heart Failure Development by Improving Myocardial Function and Reducing Fibrosis in Spontaneously Hypertensive Rats - Concepedia

Concepedia

Publication | Open Access

Early Spironolactone Treatment Attenuates Heart Failure Development by Improving Myocardial Function and Reducing Fibrosis in Spontaneously Hypertensive Rats

DOI Full Paper Access

39

Citations

47

References

2015

Year

M. D. M. Cezar, R. L. Damatto, Luana Urbano Pagan, A. R. R. Lima, Paula Felippe Martinez, Camila Bonomo, C. M. Rosa, Dijon Henrique Salomé de Campos, Antônio Carlos Cicogna, Mariana Janini Gomes,

Cellular Physiology and Biochemistry

Abstract

Early spironolactone treatment decreases heart failure development frequency by improving myocardial systolic and diastolic function and attenuating hypertrophy and fibrosis in spontaneously hypertensive rats.

References

	Year	Citations

Page 1